SCHEMBL5997204

SCHEMBL5997204

COC(=O)C(CN1C(=O)C(c2ccccc2)=C(c2ccccc2)C1=O)C(C)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.41
FGFR2 P21802 2/20 0.41
FGFR4 P22455 2/20 0.41
FGFR3 P22607 2/20 0.41
SRC P12931 1/20 0.41
ACHE P22303 1/20 0.41
NR1H2 P55055 5/20 0.40
NR1H3 Q13133 5/20 0.40
KMT2A Q03164 2/20 0.39
HSP90AA1 P07900 2/20 0.38
HSP90AB1 P08238 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PDE4B Q07343 1/20 0.37
ALDH1A1 P00352 2/20 0.36
ALOX15 P16050 1/20 0.36
MITF O75030 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CYP26A1 O43174 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5998056 0.87 TDP1 (0.43) NR1H2NR1H3KMT2AL3MBTL1ALDH1A1
SCHEMBL5998010 0.84 ALDH1A1 (0.49) KMT2AALDH1A1MAPT
SCHEMBL5998145 0.81 RGS4 (0.44) ACHEKMT2AHSP90AA1L3MBTL1ALDH1A1
SCHEMBL5998859 0.79 TNF (0.43) KMT2AL3MBTL1ALDH1A1MAPT
SCHEMBL5998394 0.77 ACHE (0.40) FGFR1FGFR2FGFR4FGFR3SRC
SCHEMBL5997459 0.76 MEN1 (0.44) KMT2AL3MBTL1ALDH1A1MAPT
SCHEMBL5996069 0.75 TNF (0.40) ACHEKMT2AL3MBTL1ALDH1A1MAPT
SCHEMBL5998955 0.75 CASP3 (0.33) ACHEKMT2APDE4BALDH1A1
SCHEMBL5998663 0.74 KMT2A (0.42) KMT2AL3MBTL1ALDH1A1MAPTHTT
SCHEMBL5997284 0.73 TNF (0.43) KMT2APDE4BALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7094908-B2 Reduction of carbonyl compounds using the carbonyl reductase of Kluyveromyces marxianus KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2006-08-22 US disclosed
US-20030139464-A1 Reduction of carbonyl compounds using the carbonyl reductase of kluyveromyces marxianus KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 2003-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139464-A1 Reduction of carbonyl compounds using the carbonyl reductase of kluyveromyces marxianus CBR1, CBR3, DCXR FGFR1 2375/4885FGFR2 3432/4885FGFR4 3115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.